Sabesan Yoganathan

The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram-negative bacteria in combination with EDTA treatment

Leah A. Martin‐Visscher, Sabesan Yoganathan, Clarissa S. Sit et al. · FEMS Microbiology Letters · 2011 · 98 citations · Full text

Edta Treatment, Bacterial Pathogens, Carnobacterium Maltaromaticum Ual307 +18

Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens

Sabesan Yoganathan, Scott J. Miller · Journal of Medicinal Chemistry · 2015 · 65 citations · Full text

Glycobiology, Molecular Biology, Peptide Science +24

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment

Nishant S. Kulkarni, Vineela Parvathaneni, Snehal K. Shukla et al. · European Journal of Pharmaceutical Sciences · 2019 · 62 citations

Medicine, Quantum Dots, Pharmacology +8

<i>N</i>-Methylimidazole-catalyzed Synthesis of Carbamates from Hydroxamic Acids via the Lossen Rearrangement

Sabesan Yoganathan, Scott J. Miller · Organic Letters · 2013 · 59 citations

Engineering, Hydroxamic Acids, Heterocyclic +10

Chemical synthesis and biological evaluation of gallidermin-siderophore conjugates

Sabesan Yoganathan, Clarissa S. Sit, John C. Vederas · Organic & Biomolecular Chemistry · 2011 · 51 citations